An immunoglobulin G3(K) monoclonal antibody (MAb), MAb 32-1-E3, which was prepared in BALB/c mice by using a heated, alcohol-acetone-extracted Sabnonella newport CDC 50 antigen, reacted with protein-free lipopolysaccharides from SabloneUla groups C2 (0:6,8) 
interest, i.e., to produce single-factor 0:6, 0:7, 0:8, 0:1A, or 0:2Q antiserum (5, 13) . Absorbed, single-factor polyclonal antisera are routinely produced and used in our laboratory to separate subgroups Cl (factors 0:6 and 0:7) from subgroups C2 (factors 0:6 and 0:8) and C3 (factor 0:8). However, single-factor antisera are made only in small volumes, have low usable titers (i.e., often must be used undiluted or diluted 1:2), often must later be reabsorbed to remove low levels of cross-reactivity that remain after initial absorption, and may produce less than optimum agglutination with bacteria containing the homologous somatic antigen factor while retaining a detectable level of reactivity against extraneous antigens.
Monoclonal antibody (MAb) reagents that are reactive in slide agglutination tests for Salmonella serogroup identification (1, 4, 15-18, [26] [27] [28] reagents as needed, without absorbtion and by simplified standardization procedures, since their specificity does not change (11) . Thus, it should be possible, over time, to prepare sets of MAb reagents suitable for identifying serogroups of Salmonella.
We report here the characteristics of an immunoglobulin G3(K) [IgG3(K)] MAb reagent that detects a factor 0:8-like antigen located on Salmonella serogroup C2 and C3 lipopolysaccharide (LPS) moieties. The MAb is useful as a replacement for the polyclonal, absorbed single-factor 0:8 antiserum commonly used for Salmonella serogroup determination.
MATERIALS AND METHODS Salmonella strains. Those strains recommended for preparation and characterization of serogrouping reagents (4, 13) were obtained originally from the Enteric Diseases Laboratory, Centers for Disease Control, Atlanta, Ga. (CDC strains), or were clinical isolates submitted to the Microbial Diseases Laboratory, California Department of Health Services, for identification (MDL strains). The strains were found to be suitable for use as immunizing antigens or for evaluating antisera. Stock strains were maintained at -70°C in a mixture of sheep blood and alundum. Working cultures were maintained at 4°C on heart infusion agar slants (Difco, Detroit, Mich.). For isolation, the bacteria were streaked onto heart infusion agar plates, and single colonies were obtained for use. The identities and antigenic contents of all strains were confirmed before use by using standard identification methods and antisera (5) . The and then at 4°C overnight, and centrifuged at 10,000 rpm as described above; the absorbed antibody was then harvested. The procedure was repeated once.
Protein-and nucleic acid-fee LPS. Overnight cultures in Roux bottles were extracted by the previously described hot phenol-water method (7, 29) , and the extract was then treated as follows to remove nucleic acids and residual proteins. The LPS, which was suspended in 120 ml of class I reagent-grade deionized water (LPS-free), was mixed with 10-mg amounts of RNase A (catalog no. R-9005; Sigma and DNase I (type II; catalog no. D-4527; Sigma) and incubated for 1 h at room temperature (ca. 23°C). Ten milligrams of proteinase K (type XXVIII; catalog no. P-4914; Sigma) was then added, and the mixture was incubated at 60°C for 1 h. After centrifugation at 9,800 x g for 30 min at 5°C (Beckman J21C centrifuge), the supernatant was recentrifuged at 90,000 x g for 4 h at 5°C (Beckman L-2 ultracentrifuge with a 25.2 rotor); and the pellet was resuspended in 120 ml of class I reagent-grade water and recentrifuged twice more, resuspended in 6 ml of class I reagent-grade water, divided into 2-ml aliquots, and freeze-dried. normal rabbit serum, was pipetted into pairs of wells and incubated for 1 h at 35°C. The supernatant from the P3x63-ag8.653 myeloma culture, which does not secrete antibody, or sterile ascites was used as a negative control. Mouse antiserum to the S. newport CDC 50 antigen, diluted 1:5,000, was used as a positive control. After incubation, the plates were washed five times as described above and were developed according to the manufacturer's instructions (Vector) by using ABTS staining reagent (catalog no. 506200; Kirkegaard and Perry, Gaithersburg, Md.). The plates were incubated for 1 h at room temperature in the dark and then read Agglutination was done by a standard slide assay with twofold dilutions, in 0.85% NaCl (saline), or serum or ascites against 50% ethanol-saline suspensions of Salmonella cultures grown overnight on brain heart infusion agar slants (5).
Polyacrylamide gel electrophoresis. Proteinase K-treated LPS, which was prepared by the procedure of Hitchcock and Brown (9), as modified by Kokka et al. (12) , was electrophoresed as described by Stein et al. (24) , except that a 6.5% stacking gel was used and 0.02% bromphenol blue (catalog no. 161-0404; Bio-Rad) was included in the sample buffer as an indicator dye. The buffer system MZE 3328.1V devised by Jovin (10) was used as described by Moos et al. (19) . Electrophoresis was performed at a constant 8.0 mA per gel for approximately 1.5 h at room temperature by using a model PS 50OX regulated power supply (Hoeffer Scientific, San Francisco, Calif.) until the indicator dye was approximately 5 mm from the bottom of the gel. The gels were then either stained directly (2, 9, 12, 25) by using a silver staining kit (catalog no. 161-0443; Bio-Rad) and photographed by using electrophoresis duplicating paper EDP (Kodak, (catalog no. 182-7831; Kodak) or used for immunoblot assays as described below.
Immunoblot assays. LPSs from sodium dodecyl sulfate (SDS)-polyacrylamide gels were electroblotted (21) The membranes were again washed three times, 4-chloro-1-napthtol (horseradish peroxidase color development reagent; catalog no. 170-6537; Bio-Rad) was added (sufficient to cover the membranes), and the solution was incubated at room temperature with gentle agitation until the color development was judged to be sufficiently intense (about 10 min). The solution was then rinsed two times in deionized water, air dried, and stored in the dark (22, 25, 28) . Periodate oxidation. The periodate oxidation method of Woodward et al. (30) was used. Individual Immobilon-P membrane strips containing LPS antigens were immersed in methanol for 3 s, rinsed in reagent-grade deionized water for 1 to 2 min, and then washed once for 5 min in 10 ml of 50 mM sodium acetate buffer (pH 4.5). Sodium periodate (catalog no. S-1147; Sigma) in 50 mM sodium acetate buffer (pH 4.5; 10 ml) was freshly prepared at 10, 50, and 200 ,uM. Individual strips were immersed in the dark for 1 h, gently agitated with a laboratory rotator, and then washed three times for 10 min each time in 10 ml of 50 mM sodium acetate buffer (pH 4.5). Freshly prepared 50 ,uM sodium borohydride (catalog no. S-9125; Sigma) in PBS was then added (10 ml), and the solution was gently agitated for 30 min and then washed three times for 10 min each time with gentle agitation in PBS containing 1% gelatin. The strips were then stained by the ETA method described above for the immunoblot assays, except that a protein A-alkaline phosphatase conjugate (catalog no. P-9650; Sigma) was used with a 5-bromo-4-chloro-3-indolylphosphate toluidinium (salt)-Nitro Blue Tetrazolium substrate (catalog no. 170-641; Bio-Rad) for visualization. The monoclonal ascites was diluted 1:320.
RESULTS
Selection of reactive MAbs. Following hybridization, 199 of 824 cultures yielded hybrid colonies for a fusion efficiency of 24.2%. Of these, seven were initially reactive by EIA (>0.5 AU) against Salmonella serogroup C2 antigens. Ascites of the three positive lines that gave the highest ETA reactions were tested by agglutination by using the homologous S. newport CDC 50 culture and strains from Salmonella serogroups A, B, Cl, C2, C3, Dl, D2, E1-E4, F, Gl, G2, H, I, and 18 through 67. The hybridoma cell line 32-1-E3, ascites from which was found to react equally well (agglutination titers of 1:32-1:64) with the homologous strain of S. newport and with the representative C2 and C3 strains tested and which did not react with any non-C2 or non-C3 strains tested, was cloned twice. The MAb was then reacted against protein-and nucleic acid-free LPS antigens prepared from S. montevideo MDL 1084 (group Cl), S. newport CDC 50 (group C2), S. typhimurium (group B; catalog no. L-6511; Sigma), S. abortus-equi (group B; catalog no. L-5886; Sigma), S. typhi (group D; catalog no. L-6386; Sigma), and an Ra mutant (TV119) of S. typhimurium (core; catalog no. L-6016; Sigma) to determine that the MAb reacted with LPS antigens of group C2 but not with group B, Cl, D, or LPS core determinants (data not shown).
Peptide composition. Supernatants from the cloned cell line were reacted with rat anti-mouse immunoglobulin isotype MAbs in parallel with positive controls. Positive controls consisted of culture supernatants containing myeloma proteins representative of each mouse immunoglobulin heavy-and light-chain isotype, not including IgE or IgD, in an antibody-capture assay. MAb 32-1-E3 was reactive only with anti-IgG3 heavy-chain and anti-K light-chain antibodies. bacteria did not reduce the titer. Significantly, absorption with neither S. cholerasuis nor S. boecker, which contain serogroup factor 0:6 but not serogroup factor 0:8, did not reduce the titer, suggesting that the specificity of the MAb is to the serogroup factor 0:8 antigen. On the basis of the titer of the unabsorbed ascites, a dilution of 1:4,000 for MAb 32-1-E3 ascites was established for further EIA studies.
Competitive inhibition with antigens. To further evaluate the specificity, the ascites were diluted 1:4,000 in the usual diluent that also contained serial 10-fold dilutions of Salmonella antigen powders in the range of 100 ,ug/ml to 0.01 ng/ml. These antigens included S. agona MDL 86A-5257 (serogroup B , and Escherichia coli CDC EDL 932 (enteric bacterium with no known Salmonella antigens). The dilutions were incubated for 1 h at room temperature, and then the EIA assay was completed in the normal fashion. Figure 2 , which plots the percent inhibition of reaction versus the concentration of inhibitor, shows that the MAb reactivity was inhibited by competition with serogroup C2 and C3 Salmonella spp., but not by competition with serogroup Cl or other, non-serogroup C bacteria, confirming that the MAb may be reactive with somatic factor 0:8.
Competitive inhibition with antisera. An additional assessment of the specificity in ELAs was performed as described above, except that the antigen-coated plates were preincubated for 1 h at room temperature with serial dilutions of rabbit anti-serogroup Cl (0:6,7), anti-serogroup C2 (0:6,8), anti-serogroup C3 (0:8,2Q), anti-serogroup B (0:4,12), and anti-serogroup H (0:6,14) in the range of 1:5 through 1:1,000 with normal rabbit serum or before incubation with MAb 32-1-E3. Figure 3 , which plots inhibition versus dilution, shows that the anti-serogroup C2 and anti-serogroup C3 antisera were equally effective at inhibiting reactivity, while the anti-serogroup Cl, anti-serogroup B, and anti-serogroup H antisera and normal rabbit serum were ineffective. Taken together, the results of the absorption and competition experiments argue that MAb 32-1-E3 is highly specific for a serogroup 0:8-like antigen and does not show any crossreactivity with antigens 0:6, 0:4, or the other serogroup antigens tested.
Location of the factor 0:8-like antigen on the LPS moiety.
To confirm the association of the 0: Figure 4A and 4C show the results of immunological staining with MAb 32-1-E3 in Western blot (immunoblot) assays with typical LPS ladder patterns only on the 0:8-containing antigens, which is consistent with the presence of the antigenic determinant on the LPS. Figure 4B and C shows duplicate silver-stained gels with typical LPS ladder patterns in all lanes. Periodate oxidation. The hexose dideoxy sugar abequose, which forms the immunodominant portion of the Salmonella 0:4 and 0:8 antigens, is not destroyed by oxidation with sodium periodate (14) . Thus, if the MAb indeed reacts with the 0:8 antigen as an immunodominant epitope, it should not be possible to inhibit the reactivity of MAb 32-1-E3 by treatment of the antigen with even high concentrations of sodium periodate. Accordingly, proteinase K-treated S. newport CDC 50 and S. paratyphi A MDL 88A6213 immunoblotted onto Immobilon-P membrane strips were left VOL. 30, 1992 on August 14, 2017 by guest http://jcm.asm.org/ 3054 DUFFEY ET AL. untreated; were put through the series of incubations and washes used for the periodate procedure, except that no sodium periodate was used; or were treated with 10, 50, or 200 ,uM sodium periodate and then with 50 ,uM sodium borohydride. The strips containing S. paratyphi type A antigens were stained immunologically by using rabbit antiserogroup A antiserum at 1:40, and the strips containing S. newport antigens were stained with the MAb 32-1-E3 ascites diluted 1:640 as described above. Figure 5 shows that reactivity of serogroup A antiserum against the S. paratyphi type A antigens (0:1,2,12), which are destroyed by periodate oxidation (18) , was inhibited by treatment with 10 ,uM Dilution Reactivity by agglutination. In order to be useful as a serogrouping reagent, it is essential that MAb 32-1-E3 be capable of agglutinating with factor 0:8-containing salmonellae, viz., group C2 and group C3, but not with any other [14] ). Inhibition by anti-Cl antibody was considered to be due to steric hindrance with the 0:6 antigen. In the present study, MAb 32-1-E3 was not inhibited by competition with anti-0:6 or other non-0:8 antibodies, and the titers of MAb 32-1-E3 were similar with all 0:8-containing antigens, suggesting that the presence of the 0:6 antigen neither enhanced nor inhibited the reactivity of MAb 32-1-E3 against factor 0:8 antigen. Accordingly, the specificity of MAb 32-1-E3 is different from that of the M08 MAb reported by Luk et al. (15) , although both antibodies appear to be similarly useful in slide agglutination assays as singlefactor serogrouping reagents for the detection of strains of Salmonella spp. that contain the 0:8 antigen.
